These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 14623053)

  • 1. Reductions in bone turnover, mineral, and structure associated with mechanical properties of lumbar vertebra and femur in glucocorticoid-treated growing minipigs.
    Ikeda S; Morishita Y; Tsutsumi H; Ito M; Shiraishi A; Arita S; Akahoshi S; Narusawa K; Nakamura T
    Bone; 2003 Nov; 33(5):779-87. PubMed ID: 14623053
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modulation of bone turnover by alfacalcidol and/or alendronate does not prevent glucocorticoid-induced osteoporosis in growing minipigs.
    Akahoshi S; Sakai A; Arita S; Ikeda S; Morishita Y; Tsutsumi H; Ito M; Shiraishi A; Nakamura T
    J Bone Miner Metab; 2005; 23(5):341-50. PubMed ID: 16133683
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ibandronate treatment reverses glucocorticoid-induced loss of bone mineral density and strength in minipigs.
    Glüer CC; Scholz-Ahrens KE; Helfenstein A; Delling G; Timm W; Açil Y; Barkmann R; Hassenpflug J; Stampa B; Bauss F; Schrezenmeir J
    Bone; 2007 Mar; 40(3):645-55. PubMed ID: 17174621
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of vascular endothelial growth factor in glucocorticoid-induced bone loss: evaluation in a minipig model.
    Pufe T; Scholz-Ahrens KE; Franke AT; Petersen W; Mentlein R; Varoga D; Tillmann B; Schrezenmeir J; Glüer CC
    Bone; 2003 Dec; 33(6):869-76. PubMed ID: 14678846
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [PHASIC CHANGES OF BONE MASS, BONE TURNOVER MARKERS, AND ESTROGEN LEVELS AT DIFFERENT TIME POINTS AFTER GLUCOCORTICOID INTERVENTION AND THEIR CORRELATION IN RATS].
    Ren H; Shen G; Jiang X; Liang D; Tang J; Cui J; Lin S; Zhuang H; Yang Z; Zhang S; Yao Z
    Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2015 Mar; 29(3):307-14. PubMed ID: 26455196
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of mineral-to-matrix ratio of lumbar trabecular bone in ovariectomized rats treated with risedronate in combination with or without vitamin K2.
    Otomo H; Sakai A; Ikeda S; Tanaka S; Ito M; Phipps RJ; Nakamura T
    J Bone Miner Metab; 2004; 22(5):404-14. PubMed ID: 15316861
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Primary prevention of glucocorticoid-induced osteoporosis with intravenous pamidronate and calcium: a prospective controlled 1-year study comparing a single infusion, an infusion given once every 3 months, and calcium alone.
    Boutsen Y; Jamart J; Esselinckx W; Devogelaer JP
    J Bone Miner Res; 2001 Jan; 16(1):104-12. PubMed ID: 11149473
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of glucocorticoid on BMD, micro-architecture and biomechanics of cancellous and cortical bone mass in OVX rabbits.
    Liu X; Lei W; Wu Z; Cui Y; Han B; Fu S; Jiang C
    Med Eng Phys; 2012 Jan; 34(1):2-8. PubMed ID: 21775186
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glucocorticosteroid-induced osteoporosis in adult primiparous Göttingen miniature pigs: effects on bone mineral and mineral metabolism.
    Scholz-Ahrens KE; Delling G; Stampa B; Helfenstein A; Hahne HJ; Açil Y; Timm W; Barkmann R; Hassenpflug J; Schrezenmeir J; Glüer CC
    Am J Physiol Endocrinol Metab; 2007 Jul; 293(1):E385-95. PubMed ID: 17456640
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of glucocorticoid on bone in 3-, 6-, and 12-month-old rats as determined by bone mass and histomorphometry.
    Ogoshi T; Hagino H; Fukata S; Tanishima S; Okano T; Teshima R
    Mod Rheumatol; 2008; 18(6):552-61. PubMed ID: 18648735
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlations between biochemical markers of bone turnover and bone density responses in patients with glucocorticoid-induced osteoporosis treated with teriparatide or alendronate.
    Burshell AL; Möricke R; Correa-Rotter R; Chen P; Warner MR; Dalsky GP; Taylor KA; Krege JH
    Bone; 2010 Apr; 46(4):935-9. PubMed ID: 20060081
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of the effects of genistein and zoledronic acid on the bone loss in OPG-deficient mice.
    Liu J; Xu K; Wen G; Guo H; Li S; Wu X; Dai R; Sheng Z; Liao E
    Bone; 2008 May; 42(5):950-9. PubMed ID: 18337202
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of stanozolol on bone mineral density and bone biomechanical properties of osteoporotic rats.
    Liao JM; Wu T; Li QN; Hu B; Huang LF; Li ZH; Yuan L; Zhong SZ
    Di Yi Jun Yi Da Xue Xue Bao; 2003 Nov; 23(11):1117-20. PubMed ID: 14625163
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intermittent minodronic acid treatment with sufficient bone resorption inhibition prevents reduction in bone mass and strength in ovariectomized rats with established osteopenia comparable with daily treatment.
    Kimoto A; Tanaka M; Nozaki K; Mori M; Fukushima S; Mori H; Shiroya T; Nakamura T
    Bone; 2013 Jul; 55(1):189-97. PubMed ID: 23486179
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bisphosphonate tiludronate increases bone strength by improving mass and structure in established osteopenia after ovariectomy in rats.
    Ohnishi H; Nakamura T; Narusawa K; Murakami H; Abe M; Barbier A; Suzuki K
    Bone; 1997 Oct; 21(4):335-43. PubMed ID: 9315337
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanical properties, bone mineral content, and bone composition (collagen, osteocalcin, IGF-I) of the rat femur: influence of ovariectomy and nandrolone decanoate (anabolic steroid) treatment.
    Aerssens J; Van Audekercke R; Geusens P; Schot LP; Osman AA; Dequeker J
    Calcif Tissue Int; 1993 Oct; 53(4):269-77. PubMed ID: 8275356
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reductions in bone mass, structure, and strength in axial and appendicular skeletons associated with increased turnover after ovariectomy in mature cynomolgus monkeys and preventive effects of clodronate.
    Itoh F; Kojima M; Furihata-Komatsu H; Aoyagi S; Kusama H; Komatsu H; Nakamura T
    J Bone Miner Res; 2002 Mar; 17(3):534-43. PubMed ID: 11874245
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glucocorticoid induced osteopenia in cancellous bone of sheep: validation of large animal model for spine fusion and biomaterial research.
    Ding M; Cheng L; Bollen P; Schwarz P; Overgaard S
    Spine (Phila Pa 1976); 2010 Feb; 35(4):363-70. PubMed ID: 20110841
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prednisolone prevents decreases in trabecular bone mass and strength by reducing bone resorption and bone formation defect in adjuvant-induced arthritic rats.
    Okazaki Y; Tsurukami H; Nishida S; Okimoto N; Aota S; Takeda S; Nakamura T
    Bone; 1998 Oct; 23(4):353-60. PubMed ID: 9763147
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term treatment with eldecalcitol (1α, 25-dihydroxy-2β- (3-hydroxypropyloxy) vitamin D3) suppresses bone turnover and leads to prevention of bone loss and bone fragility in ovariectomized rats.
    Takeda S; Smith SY; Tamura T; Saito H; Takahashi F; Samadfam R; Haile S; Doyle N; Endo K
    Calcif Tissue Int; 2015 Jan; 96(1):45-55. PubMed ID: 25467010
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.